Lodestone Biomedical

Hanover, United States Founded: 2015 • Age: 11 yrs
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
Request Access

About Lodestone Biomedical

Lodestone Biomedical is a company based in Hanover (United States) founded in 2015 by Lidia Valdes.. Lodestone Biomedical has raised $1.19 million across 5 funding rounds from investors including MassChallenge. Lodestone Biomedical operates in a competitive market with competitors including BioImage, BioAmp Diagnostics, ACS Biomarker, Araceli Biosciences and HAWK Biosystems, among others.

  • Headquarter Hanover, United States
  • Founders Lidia Valdes
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
    $957.21 K
    103
    as on Dec 31, 2023
  • Net Profit
    $-59.27 K
    67
    as on Dec 31, 2023
  • EBITDA
  • Total Equity Funding
    $1.19 M (USD)

    in 5 rounds

  • Latest Funding Round
    $75 K (USD), Seed

    Jun 29, 2025

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Lodestone Biomedical

Lodestone Biomedical has successfully raised a total of $1.19M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $75 thousand completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 5
  • Last Round Seed — $75,000
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2025 Amount Seed - Lodestone Biomedical Valuation

investors

Dec, 2021 Amount Seed - Lodestone Biomedical Valuation

investors

Apr, 2020 Amount Seed - Lodestone Biomedical Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lodestone Biomedical

Lodestone Biomedical has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage entrepreneurs are accelerated through MassChallenge's program.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lodestone Biomedical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lodestone Biomedical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lodestone Biomedical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lodestone Biomedical

Lodestone Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioImage, BioAmp Diagnostics, ACS Biomarker, Araceli Biosciences and HAWK Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Bioassays are developed for biopharmaceutical firms and research organizations.
domain founded_year HQ Location
Developers of diagnostic tests that help to treat patient with a specific antibiotic
domain founded_year HQ Location
Novel biomarkers for cardiac disease are discovered, validated, and commercialized.
domain founded_year HQ Location
Scientific tools for tissue and cell-based biomarker discovery are developed.
domain founded_year HQ Location
Clinical assays are developed for quantifying novel biomarkers in samples.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lodestone Biomedical

Frequently Asked Questions about Lodestone Biomedical

When was Lodestone Biomedical founded?

Lodestone Biomedical was founded in 2015.

Where is Lodestone Biomedical located?

Lodestone Biomedical is headquartered in Hanover, United States. It is registered at Hanover, New Hampshire, United States.

Who is the current CEO of Lodestone Biomedical?

Lidia Valdes is the current CEO of Lodestone Biomedical. They have also founded this company.

Is Lodestone Biomedical a funded company?

Lodestone Biomedical is a funded company, having raised a total of $1.19M across 5 funding rounds to date. The company's 1st funding round was a Seed of $110K, raised on Jun 01, 2015.

What is the annual revenue of Lodestone Biomedical?

Annual revenue of Lodestone Biomedical is $957.21K as on Dec 31, 2023.

What does Lodestone Biomedical do?

Lodestone Biomedical was founded in 2015 in Hanover, United States, as a provider of magnetic nanoparticle platform technology focused on immuno-oncology. The Immunotherapy Response Indication System (IRIS) is utilized to interrogate binding states of functionalized magnetic nanoparticles in needle-implantable biosensor probes. Real-time signals of treatment efficacy and response are monitored within the tumor-immune microenvironment. Operations center on in vivo biomarker detection for clinical applications.

Who are the top competitors of Lodestone Biomedical?

Lodestone Biomedical's top competitors include Araceli Biosciences, BioAmp Diagnostics and BioImage.

Who are Lodestone Biomedical's investors?

Lodestone Biomedical has 1 investor. Key investors include MassChallenge.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available